Skip to main content

Centers

Scientific discovery does not happen in isolation. It emerges from dynamic collaborations, cross-disciplinary exchange and shared ambition.

At Scripps Research, our centers and institutes bring together leading minds and bright ideas, enabling scientists to work beyond traditional boundaries and answer fundamental questions about human health and disease. These centers create a continuous cycle of insight, innovation and broader thinking.

From preparing for future global pandemics to unraveling the complexities of the human brain, Scripps Research scientists collaborate closely with one another, as well as with external research institutions and partners around the world. Together, they are exploring—and defining—new frontiers in science.


News, Events & Media
$10 million grant funds Scripps Research Alcohol Research Center through its 50th year
News

$10 million grant funds Scripps Research Alcohol Research Center through its 50th year

The five-year grant supports research into the neurobiology of alcohol use disorder.

Leading minds on COVID-19 come together for pandemic preparedness symposium, hosted by Scripps Research
News

Leading minds on COVID-19 come together for pandemic preparedness symposium, hosted by Scripps Research

Symposium marks public launch of Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)  to develop new antiviral therapies in preparation for future pandemics.

Scripps Research awarded $67 million by NIH to lead new pandemic preparedness center
News

Scripps Research awarded $67 million by NIH to lead new pandemic preparedness center

The multidisciplinary center will focus on development of antiviral drugs to combat coronaviruses and other viruses with pandemic potential.

Scripps Research licenses urine dipstick test for river blindness to IVD Research
News

Scripps Research licenses urine dipstick test for river blindness to IVD Research

IVD Research Inc., a contract development and manufacturing (CDMO)  firm in Carlsbad, California has licensed a novel biomarker for onchocerciasis—better known as river blindness—from Scripps Research in La Jolla, California. The reagent, developed in the laboratory of Kim Janda, PhD, a professor of chemistry at Scripps Research, will allow clinicians to monitor active infections of onchocerciasis.

Groundbreaking Science.
Life-changing Medicine.